AVDL AVADEL PHARMACEUTICALS PLC: institutional ownership and insider trading
10 funds reported holding $167M of AVADEL PHARMACEUTICALS PLC in their latest 13F filings; in Q2 2026 funds net bought $0, with 0 new positions and 1 funds selling out; over the last 12 months insiders bought $0 and sold $233M on the open market.
Largest institutional holders of AVDL
- VANGUARD GROUP INC — $126M
- KOTLER KEVIN — $34.9M
- Nuveen Asset Management, LLC — $3.21M
- HAP TRADING, LLC — $1.05M
- AVANTAX ADVISORY SERVICES, INC. — $858K
- HAP Trading, LLC — $379K
- WOLVERINE TRADING, LLC — $378K
- CIBC Private Wealth Group LLC — $172K
- First Horizon Advisors, Inc. — $13.6K
- Lindbrook Capital, LLC — $2.15K
Recent AVDL insider trades
- Feb 13, 2026: Weiss Asset Management LP sold 11,112,052 shares ($233M)
- Jan 21, 2025: Palczuk Linda bought 5,000 shares ($39.7K)
- Jan 13, 2025: Ende Eric J bought 30,000 shares ($235K)
- Jan 13, 2025: Thornton Peter J. bought 10,000 shares ($80.5K)
5%+ owners
- BlackRock, Inc.: 7.0% (Schedule 13G/A, filed Jul 16, 2025)
- The Vanguard Group: 5.7% (Schedule 13G, filed Jul 29, 2025)